5-(N,N-dimethyl)-Amiloride Hydrochloride: Potent NHE1 Inhibitor for Intracellular pH and Cardiac Research

Executive Summary: 5-(N,N-dimethyl)-Amiloride (hydrochloride) (DMA) is a high-affinity Na+/H+ exchanger inhibitor with nanomolar potency against NHE1 and NHE2 isoforms, allowing precise modulation of intracellular pH and sodium homeostasis in mammalian cells (doi.org/10.1155/2021/6695679). The compound displays minimal off-target action on NHE4, NHE5, and NHE7, supporting its selectivity in research applications. DMA has been shown to mitigate cardiac ischemia-reperfusion injury by normalizing sodium levels and contractility (APExBIO C3505). Its physicochemical properties, including 30 mg/ml solubility in DMSO, facilitate consistent assay performance. APExBIO provides quality assurance for each lot, supporting reproducible biomedical experiments.

Biological Rationale

The Na+/H+ exchanger (NHE) family is essential for regulating intracellular pH and sodium balance in mammalian cells. NHE1, the predominant isoform in cardiac and vascular tissues, extrudes protons in exchange for sodium ions, contributing to cell volume regulation, contractility, and adaptation to ischemic stress (Chen et al., 2021). Dysregulation of NHE1 activity is implicated in cardiac ischemia-reperfusion injury, endothelial dysfunction, and metabolic derangements. Selective inhibition of NHE1 is a validated approach for investigating these pathophysiological processes and for dissecting Na+/H+ exchanger signaling pathways. 5-(N,N-dimethyl)-Amiloride hydrochloride, as provided by APExBIO (C3505), offers researchers a potent and selective means to modulate NHE1 activity in vitro and in vivo.

Mechanism of Action of 5-(N,N-dimethyl)-Amiloride (hydrochloride)

DMA is a derivative of amiloride that acts as a reversible, competitive inhibitor of the Na+/H+ exchanger. It binds to the extracellular face of NHE isoforms, with Ki values of 0.02 μM for NHE1, 0.25 μM for NHE2, and 14 μM for NHE3. This selectivity profile means that DMA potently blocks proton extrusion and sodium influx in tissues where NHE1 and NHE2 predominate, thereby reducing intracellular sodium accumulation and preventing cytosolic alkalinization during metabolic or oxidative stress (APExBIO C3505). In addition, DMA inhibits ouabain-sensitive ATPase activity and alanine uptake in rat liver membranes, implicating broader effects on ion transport (Chen et al., 2021).

Evidence & Benchmarks

• DMA inhibits NHE1 with a Ki of 0.02 μM under standard in vitro buffer conditions (pH 7.4, 25°C), outperforming parent amiloride by >10-fold (APExBIO).
• DMA reduces sodium-dependent proton extrusion in cardiac myocytes, leading to lower cytosolic sodium and improved contractile recovery post-ischemia (Chen et al., 2021).
• DMA demonstrates protective effects in ischemia-reperfusion injury models, normalizing tissue sodium levels and limiting contractile dysfunction (MHY1485.com article).
• DMA selectively spares NHE4, NHE5, and NHE7 activity at concentrations effective against NHE1 and NHE2, minimizing off-target effects (d-lin-mc3-dma.com).
• DMA inhibits ouabain-sensitive ATP hydrolysis by 50% at 10 μM in rat liver plasma membranes, indicating auxiliary effects on sodium-potassium ATPase activity (Chen et al., 2021).

Applications, Limits & Misconceptions

DMA is widely used in research models of cardiovascular disease, ischemia-reperfusion injury, and cellular pH regulation. Its utility extends to studies of endothelial barrier function, as NHE1 activity influences vascular permeability and inflammatory responses. For instance, MSN (moesin) phosphorylation and endothelial dysfunction in sepsis are linked to Na+/H+ exchange and can be interrogated using DMA (Chen et al., 2021). For a systems-level analysis, see 5-(N,N-dimethyl)-Amiloride Hydrochloride: Unveiling New Insights, which complements this article by focusing on emerging translational applications.

Common Pitfalls or Misconceptions

• DMA is not a universal NHE inhibitor: It is selective for NHE1 and NHE2, with minimal activity on NHE4, NHE5, and NHE7 at working concentrations.
• Not suitable for long-term solution storage: DMA solutions in DMSO or DMF are unstable and should be prepared fresh for each experiment (APExBIO).
• Not for diagnostic or therapeutic use: DMA is intended strictly for research purposes and is not approved for clinical applications.
• Inhibition is reversible: Washing cells or tissue reverses DMA-induced NHE blockade; sustained inhibition requires continuous presence.
• High concentrations affect additional transporters: At >20 μM, DMA may inhibit ATPases and amino acid transporters nonspecifically.

For protocol optimization and troubleshooting, Optimizing Endothelial and pH Assays with 5-(N,N-dimethyl)-Amiloride offers benchmarked scenarios and workflow guidance, extending the practical focus of this review.

Workflow Integration & Parameters

DMA (C3505) from APExBIO is supplied as a crystalline hydrochloride salt, with a maximum solubility of 30 mg/ml in DMSO or dimethyl formamide. Stocks should be stored at -20°C and protected from moisture and light. For in vitro studies, final working concentrations typically range from 0.01 to 10 μM, depending on the NHE isoform and cell type targeted. For in vivo protocols, dosing must be titrated according to animal model and desired tissue exposure. Researchers should avoid repeated freeze-thaw cycles and use freshly prepared solutions for each experiment (APExBIO C3505). For advanced translational and assay applications, see Rethinking Endothelial Pathobiology: Strategic Insights, which updates guidance on leveraging NHE1 inhibitors in vascular biology research.

Conclusion & Outlook

5-(N,N-dimethyl)-Amiloride hydrochloride is a critical tool for dissecting Na+/H+ exchanger signaling, intracellular pH regulation, and sodium handling in cardiac, hepatic, and endothelial models. Its high selectivity and solubility enable reproducible, targeted experiments in cardiovascular and inflammation-related research. APExBIO's C3505 product ensures quality and batch-to-batch consistency for scientific investigations. Ongoing studies continue to refine the application of DMA in cellular and organ-level models of injury, metabolic dysfunction, and endothelial permeability.